Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.
Department of Medicine, National University of Singapore, Singapore.
Diabetes Care. 2021 Apr;44(4):1059-1061. doi: 10.2337/dc20-1558. Epub 2021 Feb 3.
To investigate the effect of metformin on testosterone levels in men with type 2 diabetes mellitus (T2DM).
Seventy men with newly diagnosed drug-naive T2DM and HbA >9.0% (75 mmol/mol) were treated with intensive insulin pump therapy for 5 days to achieve glucose normalization. They were randomized to control (continued on intensive insulin only) and metformin (plus metformin) groups (1:1) for 1 month. Testosterone was measured at baseline, randomization, and after 1-month treatment.
Total, free, and bioavailable testosterone increased significantly within 5 days (all < 0.001). After 1 month, compared with the control group, the metformin group had lower total (12.7 vs. 15.3 nmol/L), free (0.20 vs. 0.24 nmol/L), and bioavailable (4.56 vs. 5.31 nmol/L) testosterone (all < 0.05).
In men with T2DM, 1-month oral metformin may decrease serum testosterone levels independent of blood glucose control. The effects of long-term metformin on testosterone in men need further study.
研究二甲双胍对 2 型糖尿病(T2DM)男性患者睾酮水平的影响。
70 例新诊断、未用药的 T2DM 男性患者,HbA >9.0%(75 mmol/mol),接受强化胰岛素泵治疗 5 天以实现血糖正常化。他们被随机分为对照组(继续强化胰岛素治疗)和二甲双胍组(加用二甲双胍)(1:1),治疗 1 个月。在基线、随机分组时和治疗 1 个月后测量睾酮。
5 天内总睾酮、游离睾酮和生物可利用睾酮均显著升高(均<0.001)。1 个月后,与对照组相比,二甲双胍组总睾酮(12.7 对 15.3 nmol/L)、游离睾酮(0.20 对 0.24 nmol/L)和生物可利用睾酮(4.56 对 5.31 nmol/L)水平均较低(均<0.05)。
在 T2DM 男性中,1 个月的口服二甲双胍可能会降低血清睾酮水平,而不依赖于血糖控制。长期二甲双胍对男性睾酮的影响需要进一步研究。